Clemente-Bautista, Susana http://orcid.org/0000-0001-6272-6438
Trocóniz, Iñaki F.
Segarra-Cantón, Óscar
Salvador-Marín, Sara
Parramón-Teixidó, Carlos J.
Álvarez-Beltrán, Marina
López-Fernández, Luís A.
Colom, Helena
Cabañas-Poy, Maria J.
Gorgas-Torner, Maria Q.
Miarons, Marta
Funding for this research was provided by:
Sociedad Española de Farmacia Hospitalaria
Article History
Accepted: 20 February 2024
First Online: 20 March 2024
Declarations
:
: SCB and MMF conceived and designed the research; OSC and MAB had direct clinical responsibility for the patients; SCB and MMF participated in data acquisition and curation; IFT, SCB, and MMF performed the investigation; LAL-F and SS-M performed the genotyping; CJP performed the statistical analysis; SCB & MMF wrote the original draft; MJCP, OSC, MQGT, HCC, and IFT critically reviewed the scientific content of the manuscript; SCB and MMF obtained funds. All authors revised, read, and approved the final manuscript. All authors have read and agreed to the published version of the manuscript.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Clinical Research Ethics Committee of Hospital Universitari Vall d’Hebron (protocol code SCB-INF-2020-01; date of approval 20/03/2020).
: Informed consent was obtained from all subjects involved in the study.
: This study was funded by a grant from the Sociedad Española de Farmacia Hospitalaria 2022 (SEFH).
: The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
: Not applicable.
: Not applicable.